AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
AACR Global Scholar-in-Training Award recipients shared how the program’s professional development opportunities have impacted their careers.
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
The chairs for AACR on Campus in Malaysia share how early-career researchers can benefit from the programs in Kuala...
During his Pezcoller Foundation-AACR Award lecture, Douglas Hanahan, PhD, FAACR, highlighted ways to overcome systemic immunosuppression.